TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05658731

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurocognitive Testing
Description: California Verbal Learning Test (CVLT) and other cognition assessments.

Intervention type: OTHER
Group type: OTHER
Intervention: Neurocognitive Testing
Description: California Verbal Learning Test (CVLT) and other cognition assessments.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: Magnetic resonance imaging (MRI) using whole brain diffusion tensor imaging (DTI) and resting state functional MRI (rsfMRI).

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: MRI
Description: Magnetic resonance imaging (MRI) using whole brain diffusion tensor imaging (DTI) and resting state functional MRI (rsfMRI).

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: MRI
Description: Magnetic resonance imaging (MRI) using whole brain diffusion tensor imaging (DTI) and resting state functional MRI (rsfMRI).
Study: NCT06138548

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ossiofiber® Trimmable Fixation Nail
Description: OSSIOfiber® Trimmable Fixation Nails are equally strong in the initial stability and fixation strength - and superior in rotational resistance to traditional metal cannulated headless compression screws.\*
Study: NCT04973748

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Conditioned open-label placebo (COLP)
Description: Placebo oxycodone will be formulated to have the same physical appearance as liquid oxycodone and will be dispensed by the inpatient pharmacy and administered by the nursing staff. At all times that oxycodone or placebo medication is administered on post-operative day (POD) 1-5, the patient will undergo conditioning via exposure to a clove oil scent:~1. Conditioning (i.e. exposure to clove oil scent) with each dose of oxycodone medication on POD 1-5.~2. Scheduled placebo oxycodone medication paired with conditioning (i.e. exposure to clove oil scent) 3 times per day on POD 2-5.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Surveys about pain, opioid use and depression symptoms
Description: Surveys before surgery: Within 1 week prior to surgery, patients complete surveys about pain levels, opioid consumption, understanding of placebo effect and symptoms of depression.~Surveys after surgery: Through 6-months after surgery, patients complete surveys about pain levels, opioid consumption, side effects of opioids and symptoms of depression.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Surveys about pain, opioid use and depression symptoms
Description: Surveys before surgery: Within 1 week prior to surgery, patients complete surveys about pain levels, opioid consumption, understanding of placebo effect and symptoms of depression.~Surveys after surgery: Through 6-months after surgery, patients complete surveys about pain levels, opioid consumption, side effects of opioids and symptoms of depression.
Study: NCT05635760

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group-based Parent-implemented Social Communication Training
Description: The intervention will be taught by a speech therapist online (approximately 25 hours distributed over 6 months), with up to 8 parents in a group.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-learning-based Parent-implemented Social Communication Training
Description: Self-learning families will learn the same materials without the guidance of a therapist.
Study: NCT05564494

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bankart Repair
Description: Patients Randomized to Bankart Repair Group

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anatomic Glenoid Reconstruction
Description: Patients Randomized to Anatomic Glenoid Reconstruction Group
Study: NCT06150001

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: rocuronium-normal-saline mixture
Description: rocuronium will be pre-diluted with 2mL of normal saline. Researchers will inject the mixture into intravenous catheter.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rocuronium-lidocaine mixture
Description: rocuronium will be pre-diluted with 2mL of 2%lidocaine. Researchers will inject the mixture into intravenous catheter.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rocuronium-blood mixture
Description: Researchers will connect a syringe which contains 0.8mg/kg of rocuronium intravenous catheter, and then withdraw blood into the syringe. Finally inject the mixture into intravenous catheter.
Study: NCT06184373

Intervention type: DEVICE
Intervention: Dexcom G6/G7 CGM
Description: CGMs will be worn for a maximum of 10 days at 6-8 weeks postpartum.

Intervention type: DIAGNOSTIC_TEST
Intervention: Oral Glucose Tolerance Test
Description: At 10-12 weeks postpartum, participants will complete an oral glucose tolerance test, which involves drinking a glucose substance and having glucose levels measured a maximum of 3 times.

Intervention type: DIAGNOSTIC_TEST
Intervention: Hemoglobin A1c
Description: At 11-14 months postpartum, participants will be asked to have their blood drawn to check their hemoglobin A1c to look for signs of developed insulin resistance
Study: NCT05552430

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RelieveVRx
Description: Participants will complete daily skills-based Virtual Reality (VR) sessions for 8 weeks (an average of 6 minutes per day) to determine the feasibility of at-home VR technology to aid the recovery of acute orthopedic musculoskeletal injuries. The VR device software is equipped with pain-specific treatment modules (e.g., Pain Education, Relaxation/Interoception, Mindful Escapes, and Pain Distraction Games) derived from evidence-based principles of cognitive behavioral therapy (CBT), mindfulness, and pain neuroscience education.
Study: NCT06567418

Intervention type: DRUG
Intervention: alirocumab 75mg/2week
Description: patients continually prescribed or stopped alirocumab treatment during the follow-up visit, which depend on physician's clinical decision and patient preference

Intervention type: DRUG
Intervention: statin ± ezetimibe
Description: patients will be censored at initiation of alirocumab during the follow up visit
Study: NCT06562582

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bisoprolol Oral Tablet
Description: Timing of drug intervention after PCI

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ramipril Oral Product
Description: Timing of drug intervention after PCI

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin Oral Product
Description: Timing of drug intervention after PCI
Study: NCT05979688

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: yogic breathing exercise
Description: A typical session will begin with the yoga instructor demonstrating a breathing exercise technique. The participants will learn and practice each technique.
Study: NCT05496634

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sedantary
Description: An informative presentation

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Description: Pilates exercise therapy
Study: NCT05186727

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family History education
Description: The education, developed in partnership with community partners, intends to assist women to collect family history of breast cancer and share it with their providers.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family History education
Description: The education, developed in partnership with community partners, intends to assist women to collect family history of breast cancer and share it with their providers.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family History education
Description: The education, developed in partnership with community partners, intends to assist women to collect family history of breast cancer and share it with their providers.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Family History education
Description: The education, developed in partnership with community partners, intends to assist women to collect family history of breast cancer and share it with their providers.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Ambassador
Description: The support of a Patient Ambassador in addition to the education is also tested.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Ambassador
Description: The support of a Patient Ambassador in addition to the education is also tested.
Study: NCT05196802

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: mHeart.4u
Description: The mHeart.4U is a multiple-components intervention entailing the adoption and use of technological devices and self-management recommendations tailored to behavioural modifications (e.g. physical exercise and dietary patterns)
Study: NCT05878600

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kendall's exercise
Description: comparative effect of targeted cervical spine strengthening versus kendalls exercise will be analyzed

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cervical spine strengthening
Description: sole effect of cervical spine strengthening will be analyzed
Study: NCT06099327

Intervention type: DEVICE
Intervention: Image-based vital sign monitoring
Description: Unobtrusive, vital signs measurements with remote photoplethysmography
Study: NCT06344065

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Diphtheria, tetanus and acellular pertussis (component) combined vaccine (adsorbed)
Description: Three doses of basic immunization were administered at 3, 4, and 5 months of age, and one dose of booster immunization was administered at 18-24 months of age, for a total of four doses. The administration route for experimental vaccine is intramuscular injection of 0.5ml into the lateral deltoid muscle of the upper arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Diphtheria, tetanus and acellular pertussis combined vaccine (adsorbed)
Description: Three doses of basic immunization were administered at 3, 4, and 5 months of age, and one dose of booster immunization was administered at 18-24 months of age, for a total of four doses. The administration route for active control vaccine 1 is intramuscular injection of 0.5ml into the lateral deltoid muscle of the upper arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Diphtheria, tetanus, pertussis (acellular, component), poliomyelitis (inactivated) vaccine (adsorbed) and Haemophilus influenzae type b conjugate vaccine
Description: Three doses of basic immunization were administered at 3, 4, and 5 months of age, and one dose of booster immunization was administered at 18-24 months of age, for a total of four doses. The administration route for active control vaccine 2 is through intramuscular injection of 0.5ml into the anterolateral side of the thigh or the upper arm.
Study: NCT04943536

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bicalutamide
Description: localized anti-androgen therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy
Description: localized radiation therapy
Study: NCT04996992

Intervention type: PROCEDURE
Intervention: MR-guided focused ultrasound
Description: MR-guided focused ultrasound pallidothalamic tractotomy is a minimally invasive and effective procedure for thetreatment of Parkinson's disease(PD) patients.
Study: NCT05802797

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Algae Oil Fortified Soymilk
Description: Flavored soymilk beverage fortified with 0.4% algae oil with both EPA and DHA

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Algae Oil Capsule
Description: Algae oil capsules with EPA and DHA
Study: NCT06533111

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Epic Health Record semi-structured handoff cognitive aid
Description: Epic Health Record cognitive aid will be used for intraoperative anesthesia handoff
Study: NCT06102421

Intervention type: DEVICE
Intervention: BTL-6000 FSWT
Description: Low-energy focused extracorporeal shockwave therapy will be applied 4 times with an interval of 7 days from the BTL-6000 FSWT device with piezoelectric generator. The energy can vary between 0.12-0.20 mJ/mm2 based on the pain toleration, frequency 5 Hz, total number of shocks 2x2000. The application of the first set of shocks will be semi-static at the location of the largest USG defined pathology in the patellar tendon and the second set of shocks will be performed dynamically to the proximal tendon. These parameters were selected in accordance to ISMST guidelines.
Study: NCT06533111

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Epic Health Record cognitive aid will not be used for intraoperative anesthesia handoff
Study: NCT05647512

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LM-305
Description: Administered intravenously
Study: NCT04556227

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simultaneous Cycle/Cognitive Training
Description: Two weeks after discharge from the hospital the intervention group will complete recumbent cycle for 1 hour, 2x/wk. for 12 weeks (24 sessions). 10-minute cycle warm-up, 40-minute simultaneous cycling and cognitive training, 10-minute cool down. Cycling based on provider prescription and progression of physical recovery. Cognitive training program from Posit Science, Brain HQ (TM) progressive level of difficulty. Total duration of 60 minutes.
Study: NCT06470373

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RBS-001 Solution for intravitreal injection
Description: Administer 2 mg/eye (50 uL/eye) per dose of the IP via IVT to the subjects' study eye
Study: NCT05647512

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LM-305
Description: Administered intravenously

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Administered orally
Study: NCT06192771

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ESSI-SURG
Description: Patients will receive 3 face-to-face sessions with a speech-language pathologist (SLP), each with a specific goal, namely: pre-surgical educational, a post-operative day 3 therapy, and post-operative day 7 therapy. Following discharge from hospital, participants will be seen by an SLP for 4 weekly sessions, offered via telehealth or face-to-face depending on the patient's clinic schedule and/or availability.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard-of-Care
Description: Participants will receive the current standard of care, which includes a referral to SLP in response to suspicion of a swallowing problem from either assessment by the medical team and/or patient report.
Study: NCT05867394

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stress ball
Description: Stress ball squeeze
Study: NCT05304559

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-Ketamine
Description: S-Ketamine0.1mg/kg was injected intravenously during anesthesia induction and S-Ketamine0.1mg/ (kg.h) was injected intravenously during anesthesia maintenance.S-Ketamine was put into the analgesia pump as an adjuvant for continuous analgesia until 2 days after operation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous iliac fascia space block
Description: After admission, the iliac fascia space block and catheterization were performed under the guidance of ultrasound, and the analgesia was continued until two days after operation.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline0.1ml/kg was injected intravenously during anesthesia induction and Normal saline0.1ml/ (kg.h) was injected intravenously during anesthesia maintenance.Normal saline was put into the analgesia pump as an adjuvant for continuous analgesia until 2 days after operation.
Study: NCT05167344

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Relationships Program-Enhanced
Description: The Healthy Relationships Program-Enhanced (HRP-E) is a small group mental health promotion and healthy relationship program designed for vulnerable, at-risk youth. It is a trauma-informed, 16-session manualized program.
Study: NCT05596669

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: to examine the pain-relieving effects of ketamine vs ketamine magnesium infusion, as well as their influence on postoperative morphine consumption following nephrectomy; the secondary goal is to assess hemodynamic effects and pain severity

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: to examine the pain-relieving effects of ketamine vs ketamine magnesium infusion, as well as their influence on postoperative morphine consumption following nephrectomy; the secondary goal is to assess hemodynamic effects and pain severity
Study: NCT05434312

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TGRX-678
Description: Participants are given TGRX-678 tablets orally at one of the dose levels as pre-determined for the dose escalation sequence.
Study: NCT04796610

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mopati
Description: The intervention will provide training to health care providers on how to guide unsuppressed HIV patients in the selection of treatment partners. The Mopati program will provide education to patients and their treatment partners about HIV treatment and how treatment partners can support patients in treatment adherence.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mopati
Description: The intervention will provide training to health care providers on how to guide unsuppressed HIV patients in the selection of treatment partners. The Mopati program will provide education to patients and their treatment partners about HIV treatment and how treatment partners can support patients in treatment adherence.
Study: NCT06200805

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tai ji quan
Description: 24-Style Taijiquan as an Intervention for College Students with Insomnia

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: tai ji quan
Description: 24-Style Taijiquan as an Intervention for College Students with Insomnia
Study: NCT06335771

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary consultation weight loss intervention
Description: Participants will meet with a member of the study team biweekly for about 6 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary consultation weight loss intervention
Description: Participants will meet with a member of the study team biweekly for about 6 months.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary consultation weight loss intervention
Description: Participants will meet with a member of the study team biweekly for about 6 months.
Study: NCT05574348

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic Protocol in 2 Sessions (PO2S)
Description: PO2S works on the principle that there is a concordance between the author's Preferential Torsion Pattern (PTP) and the rotatory direction of osteopathic dysfunctions.~The PO2S consists of two sessions of 30 minutes each, one week apart. A 13-item clinical examination is performed at the first session. It focuses on caused pain tests, and classifies patients in left or right PTP. During the first session 14 normalizations of joint, muscular, ligament and visceral dysfunctions are performed systematically. During the second session 10 normalizations of joint, muscular, ligament and visceral dysfunctions are performed .~PO2S is an innovative osteopathic protocol for back pain.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic Protocol in 2 Sessions (PO2S)
Description: PO2S works on the principle that there is a concordance between the author's Preferential Torsion Pattern (PTP) and the rotatory direction of osteopathic dysfunctions.~The PO2S consists of two sessions of 30 minutes each, one week apart. A 13-item clinical examination is performed at the first session. It focuses on caused pain tests, and classifies patients in left or right PTP. During the first session 14 normalizations of joint, muscular, ligament and visceral dysfunctions are performed systematically. During the second session 10 normalizations of joint, muscular, ligament and visceral dysfunctions are performed .~PO2S is an innovative osteopathic protocol for back pain.
Study: NCT06377839

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Advanced platelet-rich fibrin in the ekstraction socket
Description: Advanced platelet-rich fibrin is a centrifuged fibrin matrix composed of concentrated growth factors, platelet cytokines, and blood cells, which possesses the ability to stimulate wound healing and tissue regeneration. Advanced platelet-rich fibrin is manufacturing from a blood sample.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Advanced platelet-rich fibrin in the ekstraction socket
Description: Advanced platelet-rich fibrin is a centrifuged fibrin matrix composed of concentrated growth factors, platelet cytokines, and blood cells, which possesses the ability to stimulate wound healing and tissue regeneration. Advanced platelet-rich fibrin is manufacturing from a blood sample.
Study: NCT05856292

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Teach Back
Description: Standard cancer pain educational intervention enhanced with teach-back method

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Standard cancer pain educational intervention without enhancement
Study: NCT04886141

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset
Description: To determine if virtual reality headsets can reduce a patients pain level instead of using the standard Nitrous. This may provide a alternate to patients who cannot receive nitrous if pain or anxiety can be reduced effectively.
Study: NCT04689737

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doravirine
Description: Participants will be told to take one tablet of doravirine (Pifeltro, MDS) once daily, with or without food, approximately at the day time that they usually finish the hemodialysis sessions. The rest of their antiretroviral regimen and concomitant medications will remain unchanged
Study: NCT05061446

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etrasimod
Description: Etrasimod tablet by mouth, once daily for 12 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etrasimod
Description: Etrasimod tablet by mouth, once daily for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Etrasimod matching placebo tablet by mouth, once daily up to 12 weeks